Literature DB >> 2459417

Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.

T Toyoda1, B Gotoh, T Sakaguchi, H Kida, Y Nagai.   

Abstract

Nucleotide sequence analysis of F protein antigenic variants of Newcastle disease virus mapped three distinct antigenic determinants to positions 343, 72, and 161 on the protein. The high fusion-inhibiting and neutralizing capacities of all of the monoclonal antibodies used for selection suggested close functional and structural relationships of the three positions with the fusion-inducing N-terminal region of the F1 subunit. The former two positions were located at the cysteine cluster domain near the C terminus of the F1 subunit and at the major hydrophilic domain in the F2 subunit, respectively, and both domains appeared to represent the major antigenic determinants of paramyxovirus F protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459417      PMCID: PMC253888     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.

Authors:  M J Gething; J M White; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.

Authors:  Y Nagai; H D Klenk; R Rott
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

3.  The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses.

Authors:  T Barrett; D K Clarke; S A Evans; B K Rima
Journal:  Virus Res       Date:  1987-11       Impact factor: 3.303

4.  Cloning and sequencing of the mumps virus fusion protein gene.

Authors:  M N Waxham; A C Server; H M Goodman; J S Wolinsky
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

5.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

6.  Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells.

Authors:  M Homma; M Ouchi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

7.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

8.  Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.

Authors:  N S Millar; P Chambers; P T Emmerson
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

9.  Fusion glycoprotein (F) of rinderpest virus: entire nucleotide sequence of the F mRNA, and several features of the F protein.

Authors:  K Tsukiyama; Y Yoshikawa; K Yamanouchi
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  34 in total

1.  Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain.

Authors:  C Wang; G Raghu; T Morrison; M E Peeples
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

5.  Genetic diversity of newcastle disease virus in wild birds and pigeons in West Africa.

Authors:  Chantal J Snoeck; Adeniyi T Adeyanju; Ademola A Owoade; Emmanuel Couacy-Hymann; Bello R Alkali; Ulf Ottosson; Claude P Muller
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

6.  High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: cocirculation of genotype XIV and newly defined genotypes XVII and XVIII.

Authors:  Chantal J Snoeck; Ademola A Owoade; Emmanuel Couacy-Hymann; Bello R Alkali; Mbah P Okwen; Adeniyi T Adeyanju; Giscard F Komoyo; Emmanuel Nakouné; Alain Le Faou; Claude P Muller
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

7.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation.

Authors:  M Ito; M Nishio; M Kawano; S Kusagawa; H Komada; Y Ito; M Tsurudome
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

Authors:  K V Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

Authors:  Y Ohnishi; T Shioda; K Nakayama; S Iwata; B Gotoh; M Hamaguchi; Y Nagai
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.